Amanda L Prince1, Jun Ma1, Paranthaman S Kannan1, Manuel Alvarez1, Tate Gisslen1, R Alan Harris1, Emma L Sweeney1, Christine L Knox1, Donna S Lambers1, Alan H Jobe1, Claire A Chougnet1, Suhas G Kallapur1, Kjersti M Aagaard1. 1. Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Abstract
BACKGROUND: Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality and is not uncommonly associated with chorioamnionitis. We recently have demonstrated that the placenta harbors a unique microbiome with similar flora to the oral community. We also have shown an association of these placental microbiota with PTB, history of antenatal infection, and excess maternal weight gain. On the basis of these previous observations, we hypothesized that the placental membranes would retain a microbiome community that would vary in association with preterm birth and chorioamnionitis. OBJECTIVE: In the current study, we aimed to examine the differences in the placental membrane microbiome in association with PTB in both the presence and absence of chorioamnionitis and/or funisitis using state-of-the-science whole-genome shotgun metagenomics. STUDY DESIGN: This was a cross-sectional analysis with 6 nested spontaneous birth cohorts (n = 9-15 subjects/cohort): Term gestations without chorioamnionitis, term with chorioamnionitis, preterm without chorioamnionitis, preterm with mild chorioamnionitis, preterm with severe chorioamnionitis, and preterm with chorioamnionitis and funisitis. Histologic analysis was performed with Redline's criteria, and inflammatory cytokines were analyzed in the cord blood. DNA from placental membranes was extracted from sterile swabs collected at delivery, and whole-genome shotgun sequencing was performed on the Illumina HiSeq platform. Filtered microbial DNA sequences were annotated and analyzed with MG-RAST (ie, Metagenomic Rapid Annotations using Subsystems Technology) and R. RESULTS: Subjects were assigned to cohorts on the basis of gestational age at delivery and independent scoring of histologic chorioamnionitis. We found that preterm subjects with severe chorioamnionitis and funisitis had increases in cord blood inflammatory cytokines. Of interest, although the placental membrane microbiome was altered in association with severity of histologic chorioamnionitis (permutational multivariate analysis of variance P = .005), there was no observable impact with either betamethasone or antibiotic treatment. In preterm subjects with chorioamnionitis, we found a high abundance of both urogenital and oral commensal bacteria. These alterations in the microbiome were accompanied by significant variation (P < .05) in microbial metabolic pathways important in the glucose-fed pentose phosphate pathway (term subjects), or glycerophopholipid metabolism, and the biosynthesis of the siderophore group nonribosomal peptides (preterm subjects). CONCLUSION: Consistent with ours and others previous findings, women who experienced spontaneous PTB harbor placental microbiota that further differed by severity of chorioamnionitis. Integrative metagenomic analysis revealed significant variation in distinct bacterial metabolic pathways, which we speculate may contribute to risk of preterm birth with and without severe chorioamnionitis.
BACKGROUND: Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality and is not uncommonly associated with chorioamnionitis. We recently have demonstrated that the placenta harbors a unique microbiome with similar flora to the oral community. We also have shown an association of these placental microbiota with PTB, history of antenatal infection, and excess maternal weight gain. On the basis of these previous observations, we hypothesized that the placental membranes would retain a microbiome community that would vary in association with preterm birth and chorioamnionitis. OBJECTIVE: In the current study, we aimed to examine the differences in the placental membrane microbiome in association with PTB in both the presence and absence of chorioamnionitis and/or funisitis using state-of-the-science whole-genome shotgun metagenomics. STUDY DESIGN: This was a cross-sectional analysis with 6 nested spontaneous birth cohorts (n = 9-15 subjects/cohort): Term gestations without chorioamnionitis, term with chorioamnionitis, preterm without chorioamnionitis, preterm with mild chorioamnionitis, preterm with severe chorioamnionitis, and preterm with chorioamnionitis and funisitis. Histologic analysis was performed with Redline's criteria, and inflammatory cytokines were analyzed in the cord blood. DNA from placental membranes was extracted from sterile swabs collected at delivery, and whole-genome shotgun sequencing was performed on the Illumina HiSeq platform. Filtered microbial DNA sequences were annotated and analyzed with MG-RAST (ie, Metagenomic Rapid Annotations using Subsystems Technology) and R. RESULTS: Subjects were assigned to cohorts on the basis of gestational age at delivery and independent scoring of histologic chorioamnionitis. We found that preterm subjects with severe chorioamnionitis and funisitis had increases in cord blood inflammatory cytokines. Of interest, although the placental membrane microbiome was altered in association with severity of histologic chorioamnionitis (permutational multivariate analysis of variance P = .005), there was no observable impact with either betamethasone or antibiotic treatment. In preterm subjects with chorioamnionitis, we found a high abundance of both urogenital and oral commensal bacteria. These alterations in the microbiome were accompanied by significant variation (P < .05) in microbial metabolic pathways important in the glucose-fed pentose phosphate pathway (term subjects), or glycerophopholipid metabolism, and the biosynthesis of the siderophore group nonribosomal peptides (preterm subjects). CONCLUSION: Consistent with ours and others previous findings, women who experienced spontaneous PTB harbor placental microbiota that further differed by severity of chorioamnionitis. Integrative metagenomic analysis revealed significant variation in distinct bacterial metabolic pathways, which we speculate may contribute to risk of preterm birth with and without severe chorioamnionitis.
Authors: Yiping W Han; Akihiko Ikegami; Nabil F Bissada; Melissa Herbst; Raymond W Redline; Graham G Ashmead Journal: J Clin Microbiol Date: 2006-04 Impact factor: 5.948
Authors: Mary A Zimmerman; Nagendra Singh; Pamela M Martin; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Huidong Shi; Keith D Robertson; David H Munn; Kebin Liu Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-04-19 Impact factor: 4.052
Authors: Daniel B DiGiulio; Benjamin J Callahan; Paul J McMurdie; Elizabeth K Costello; Deirdre J Lyell; Anna Robaczewska; Christine L Sun; Daniela S A Goltsman; Ronald J Wong; Gary Shaw; David K Stevenson; Susan P Holmes; David A Relman Journal: Proc Natl Acad Sci U S A Date: 2015-08-17 Impact factor: 11.205
Authors: Tara M Randis; Shari E Gelber; Thomas A Hooven; Rosanna G Abellar; Leor H Akabas; Emma L Lewis; Lindsay B Walker; Leah M Byland; Victor Nizet; Adam J Ratner Journal: J Infect Dis Date: 2014-01-28 Impact factor: 5.226
Authors: Jennifer H Steel; Sotiris Malatos; Nigel Kennea; A David Edwards; Lynda Miles; Philip Duggan; Peter R Reynolds; Robert G Feldman; Mark H F Sullivan Journal: Pediatr Res Date: 2005-01-19 Impact factor: 3.756
Authors: Samantha J Dando; Ilias Nitsos; Suhas G Kallapur; John P Newnham; Graeme R Polglase; J Jane Pillow; Alan H Jobe; Peter Timms; Christine L Knox Journal: PLoS One Date: 2012-01-12 Impact factor: 3.240
Authors: Kjersti Aagaard; Kevin Riehle; Jun Ma; Nicola Segata; Toni-Ann Mistretta; Cristian Coarfa; Sabeen Raza; Sean Rosenbaum; Ignatia Van den Veyver; Aleksandar Milosavljevic; Dirk Gevers; Curtis Huttenhower; Joseph Petrosino; James Versalovic Journal: PLoS One Date: 2012-06-13 Impact factor: 3.240
Authors: Amanda L Prince; Ryan M Pace; Tyler Dean; Diana Takahashi; Paul Kievit; Jacob E Friedman; Kjersti M Aagaard Journal: Am J Primatol Date: 2019-05-07 Impact factor: 2.371
Authors: Shreyas V Kumbhare; Dhrati V V Patangia; Ravindra H Patil; Yogesh S Shouche; Nitinkumar P Patil Journal: J Biosci Date: 2019-06 Impact factor: 1.826
Authors: Akila Subramaniam; William J Van Der Pol; Travis Ptacek; Elena Lobashevsky; Cherry Neely; Joseph R Biggio; Elliot J Lefkowitz; Casey D Morrow; Rodney K Edwards Journal: J Matern Fetal Neonatal Med Date: 2018-07-22